JPRN-UMIN000010594招募中未知
ucleotide analog and/or peginterferon alpha-2a therapy for HBeAg-negative chronic hepatitis B. - PANACHE
Gunma University Graduate School of Medicine0 个研究点目标入组 35 人开始时间: 2013年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. patients receiving Shosaikoto. 2. patients with past history of interstitial pneumonitis. 3. patients with past history of hypersensitivity to peginterferon alpha-2a and other interferons. 4. patients with past history of hypersensitivity to biological products such as vaccine. 5. pregnant women, women who may be expecting a child or lactating woman. 6. patients with chronic renal failure or severe renal dysfunction with less than or equal to 50 mL/min Ccr. 7.patients with severe depression, suicidal thinking or suicide attempt or past history of any of these diseases. 8. patients with severe liver dysfunction. 9. patients with chronic hepatitis such as autoimmune hepatitis and alcoholic hepatitis. 10. patients judged as inappropriate by the attending physician. 11. patients with less than 1.9 LogIU/mL HBsAg and less than 2.9LogIU/mL HBcrAg.
研究者
相似试验
进行中（未招募）
不适用
use of interferon to control the virological rise after discontinuation of antiretroviral treatment in patients with chronic HIVEUCTR2011-004693-29-ITISTITUTO NAZIONALE DELLE MALATTIE INFETTIVE LAZZARO SPALLANZANI40
招募中
不适用
Effect of nucleosid analog and peginterferon alfa 2a sequential therapy on patients with chronic hepatitis BChronic hepatitis BJPRN-UMIN000013811General Internal Medicine2 Kawasaki Medical School50
进行中（未招募）
不适用
Konsekutive Aderlass- und Peginterferon alfa-2a -Ribavirin-Standardtherapie im Vergleich zu einer Peginterferon alfa-2a-Ribavirin-Standardtherapie bei naiven Patienten mit HCV Genotyp 1 und Ferritin > 200 µg/l - KAPRIEUCTR2006-000504-17-DEHeinrich-Heine-Universität Düsseldorf
进行中（未招募）
不适用
Treatment with Peg-interferon alfa-2a and ribavirin in patients with hepatitis HCV-related, with or without HIV co-infection, and end stage renal disease on dialysis - NDChonic hepatitis HCV-relatedMedDRA version: 9.1Level: SOCClassification code 10019805MedDRA version: 9.1Level: SOCClassification code 10038359EUCTR2010-023245-30-ITISTITUTO NAZIONALE DELLE MALATTIE INFETTIVE LAZZARO SPALLANZANI
Unknown
不适用
Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver FibrosisLiver FibrosisHepatitis BNCT03920605Third Affiliated Hospital, Sun Yat-Sen University100